Improving Survivorship Care for Older Adults After Chemotherapy

a study on Survivorship

Summary

Eligibility
for people ages 65 years and up (full criteria)
Location
at Clovis, California
Dates
study started
completion around
Principal Investigator
by Haifaa Abdulhaq, MD
Headshot of Haifaa Abdulhaq
Haifaa Abdulhaq

Description

Summary

The researchers want to find out if older adults receiving a survivorship care plan followed by a geriatric assessment visit improves quality of life and satisfaction with care compared to receiving only a survivorship care plan for older adults who have completed chemotherapy for cancer treatment.

Details

This study is a pilot randomized trial to examine whether a geriatric assessment-enhanced survivorship care plan improves satisfaction, knowledge and health-related quality of life compared to standard survivorship care plans among older adults who have completed curative chemotherapy for cancer. The investigator's hypothesis is that older adults who receive a geriatric assessment-enhanced survivorship care plan will report improved satisfaction with care, health-related quality of life, and knowledge and preparedness for survivorship care needs.

Keywords

Survivorship, survivorship care, Chemo, chemotherapy, older, survivor, Geriatric Assessment

Eligibility

You can join if…

Open to people ages 65 years and up

  1. age 65 years and above and
  2. Have diagnosis of cancer and have completed chemotherapy with curative (not palliative) intent and
  3. have been scheduled to receive a survivorship care plan from an oncology navigator.

You CAN'T join if...

  1. advanced dementia or serious cognitive impairment that would impede ability to participate in the interview
  2. nursing home resident.

Location

  • Community Cancer Institute accepting new patients
    Clovis California 93611 United States

Lead Scientist at UCSF

  • Haifaa Abdulhaq, MD
    Haifaa Abdulhaq, M.D. is Clinical Professor in Hematology and Oncology, UCSF and she is the director of hematology at UCSF Fresno and the director of Hematology/Oncology fellowship program at UCSF Fresno.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT04405115
Study Type
Interventional
Participants
Expecting 70 study participants
Last Updated
Contact us about this trial